Mounjaro manufacturer Eli Lilly and other drugmakers are suing multiple telehealth companies for promoting compounded versions of their drugs
Randerath W, Grote L, Stenlf K, et al
The SELECT safety analysis found breast cancer rates were marginally lower on semaglutide than placebo, and a 2025 meta-analysis of 50 randomised GLP-1 trials found no increased breast cancer risk
Regular check-ups and being vigilant about any changes in your health can be crucial in catching serious conditions early on, leading to more effective treatment options
It sits in a group of treatments known as skin boosters, which a research review describes as a wide array of ingredients employed to enhance and improve skin condition when placed into the skin, marking a shift away from using injectables purely to plump one area, as noted in this skin booster classification paper
In contrast, female knockout mice exhibited elevated energy expenditure throughout the dark/active phase (Fig